BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 32642756)

  • 1. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report.
    Ito Y; Takazono T; Koga S; Nakano Y; Ashizawa N; Hirayama T; Tashiro M; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Izumikawa K; Mukae H
    BMC Infect Dis; 2021 Jun; 21(1):573. PubMed ID: 34126952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aneuploidy Is Associated with Azole Resistance in Aspergillus fumigatus.
    Khateb A; Gago S; Bromley M; Richardson M; Bowyer P
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0125322. PubMed ID: 36975834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
    Chowdhary A; Sharma C; Hagen F; Meis JF
    Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Aspergillus fumigatus azole resistance in azole-naïve patients with chronic obstructive pulmonary disease and their homes.
    Dauchy C; Bautin N; Nseir S; Reboux G; Wintjens R; Le Rouzic O; Sendid B; Viscogliosi E; Le Pape P; Arendrup MC; Gosset P; Fry S; Fréalle E
    Indoor Air; 2018 Mar; 28(2):298-306. PubMed ID: 29082624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of azole resistant-
    Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
    J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
    [No Abstract]   [Full Text] [Related]  

  • 8. [The Current Status of Drug-resistant Aspergillus].
    Tashiro M; Izumikawa K
    Med Mycol J; 2016; 57(3):J103-12. PubMed ID: 27581778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis.
    Takazono T; Ito Y; Tashiro M; Nakano Y; Hirayama T; Hosogaya N; Saijo T; Yamamoto K; Imamura Y; Miyazaki T; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    J Infect Chemother; 2021 Mar; 27(3):537-539. PubMed ID: 33309631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
    J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
    Salehi Z; Sharifynia S; Jamzivar F; Shams-Ghahfarokhi M; Poorabdollah M; Abtahian Z; Nasiri N; Marjani M; Moniri A; Salehi M; Tabarsi P; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2023 Jul; 42(7):853-864. PubMed ID: 37142789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru.
    Bustamante B; Illescas LR; Posadas A; Campos PE
    Med Mycol; 2020 Jan; 58(1):54-60. PubMed ID: 31329931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
    Hamprecht A; Morio F; Bader O; Le Pape P; Steinmann J; Dannaoui E
    Mycopathologia; 2018 Feb; 183(1):151-160. PubMed ID: 28653258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
    Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.
    Seufert R; Sedlacek L; Kahl B; Hogardt M; Hamprecht A; Haase G; Gunzer F; Haas A; Grauling-Halama S; MacKenzie CR; Essig A; Stehling F; Sutharsan S; Dittmer S; Killengray D; Schmidt D; Eskandarian N; Steinmann E; Buer J; Hagen F; Meis JF; Rath PM; Steinmann J
    J Antimicrob Chemother; 2018 Aug; 73(8):2047-2053. PubMed ID: 29684150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis.
    Moazam S; Eades CP; Muldoon EG; Moore CB; Richardson MD; Rautemaa-Richardson R
    Mycoses; 2020 Apr; 63(4):376-381. PubMed ID: 31981256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive Genetic Diversity and Widespread Azole Resistance in Greenhouse Populations of Aspergillus fumigatus in Yunnan, China.
    Zhou D; Korfanty GA; Mo M; Wang R; Li X; Li H; Li S; Wu JY; Zhang KQ; Zhang Y; Xu J
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568450
    [No Abstract]   [Full Text] [Related]  

  • 18. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
    J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens].
    Doğan Ö; Gülmez D; Arıkan Akdağlı S
    Mikrobiyol Bul; 2020 Apr; 54(2):291-305. PubMed ID: 32723284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.